<!doctype html>
<html>
<head>
<meta charset="utf-8">
<title>CV Julie</title>
<!--red tab headers -->

<script src="SpryAssets/SpryTabbedPanels.js" type="text/javascript"></script>
<link href="SpryAssets/SpryTabbedPanels.css" rel="stylesheet" type="text/css">
</head>

<body>
<div id="TabbedPanels1" class="TabbedPanels">
  <ul class="TabbedPanelsTabGroup">
    <li class="TabbedPanelsTab" tabindex="0">
      <h1>Work experience</h1></li>
    <li class="TabbedPanelsTab" tabindex="1"><h1>Qualifications</h1></li>
    <li class="TabbedPanelsTab" tabindex="2"><h1>Skills</h1></li>
    <li class="TabbedPanelsTab" tabindex="3"><h1>Funding and awards</h1></li>
    <li class="TabbedPanelsTab" tabindex="4"><h1>Personal information</h1></li>
    <li class="TabbedPanelsTab" tabindex="5"><h1>Publications</h1></li>
    <li class="TabbedPanelsTab" tabindex="5"><h1>Book Chapters</h1></li>
    <a style="text-decoration:none" href="http://hendec.homeserver.com"><li class="TabbedPanelsTab" tabindex="5"><h1>Hendec Home</h1></li> <a>
  </ul>
  
  <div class="TabbedPanelsContentGroup">
    <div class="TabbedPanelsContent">
    <ul>
  		<li>2011-present	Senior Research Associate, School of Biological Sciences, UEA, UK
    		“A Modular Active Nano-Platform for Advanced Cancer Management: 
  			Core Nanosystems, Tumor Targeting and Penetration, Molecular Imaging & Degradome based Therapy” – FP7 SaveMe programme</li>
  		<li>2010-2011	Senior Research Associate, School of Biological Sciences, UEA, UK
   			“Pilot investigation of MC1R activated signalling in cutaneous malignant melanoma”</li>
  		<li>2009-2010	Senior Research Associate, School of Biological Sciences, UEA, UK
  			“The role of MMP8 as tumour suppressor in breast cancer.”</li>
  		<li>2008-2009	Senior Research Associate, School of Biological Sciences, UEA, UK
    		“Hepsin as a biomarker for prostate cancer.” </li>
  		<li>2003-2008	Coordinator breast cancer blood & tissue bank, Multidisciplinary Breast Centre, Cancer Institute Leuven, Belgium</li>
	</ul></div>
    
    <div class="TabbedPanelsContent">
    <ul>
  		<li>2003-2008	PhD in Medical Sciences, Faculty of Medicine, KULeuven, Belgium
    		“The clinical relevance of (circulating) proteases in breast cancer: matrix metalloproteinases and cathepsins.”</li>
  		<li>1998-2002	Master in Biomedical Sciences, Vrije Universiteit Brussel (VUB), Belgium
    		“Might heterozygous BRCA1- and BRCA2- mutation have an influence on the stability of the genomic DNA?”</li>
	</ul></div>
    
    <div class="TabbedPanelsContent">
    <ul>
  		<h2>Lab techniques</h2>
		<ul>
  			<li>molecular biology: site-directed mutagenesis, cloning, RNA/DNA-extraction, real time RT- PCR, siRNA gene silencing, ELISA, Western 				blot, MTT 									assay</li>
  			<li>cellular biology: immunohistochemistry, immunofluorescence, confocal microscopy,  time-lapse videomicroscopy</li>
  			<li>cell culture: 2D and 3D mammalian cell culture, Tet-off lentiviral inducible system</li>
  			<li>in vivo work: general husbandry, PyMT cancer mouse model </li>
		</ul>
		<h2>Team work and supervision</h2>
		<ul>
  			<li>supervision of PhD student, School of Biological Sciences, UEA, 2010-present</li>
  			<li>supervision of third year undergraduate students for 8 week lab project, School of Biological Sciences, UEA, 2009-present</li>
  			<li>chair of Research Staff Forum, UEA, 2010-present member of Research Staff safety committee, UEA, 2009-present</li>
  			<li>staff representative for School of Biological Sciences, UEA, 2011-present</li>
  			<li>organizer of “Research Staff workshops” and “Woman career event”, UEA, 2010-present</li>
			</ul>
		<h2>Communication and teaching</h2>
		<ul>
			<li>Public engagement through monthly lab visits for trustees and fundraisers of cancer charities (Big C, CRUK), School of Biological Sciences, UEA, 2009-present</li>
  			<li>Media coverage by Vlaamse Liga tegen Kanker  (Belgium), Big C (UK), Coast2Coast cycle club (UK), AquaTerra Energy (UK), EDP (UK)</li>
  			<li>Seminar leader and assessor of Cancer biology course, third year undergraduates, School of Biological Sciences, UEA, 2008-present</li>
  			<li>Supervisor and assessor of 8 week long honor’s degree lab project, School of Biological Sciences, UEA, 2009-present</li>
		</ul>
		<h2>Project and time management</h2>
		<ul>
  			<li>Grant financial manager and project manager of European Framework FP7 Programme SaveMe project at UEA, UK, 2012-present</li>
  			<li>Project manager of European Framework FP6 Programme “Cancerdegradome” project at KULeuven, Belgium, 2004-2007</li>
  			<li>Forged a number of international collaborations at KULeuven, 2004-2007</li>
		</ul>
		<h2>Information Technology</h2>
		<ul>
 			<li>Word, Excel, Powerpoint, Access</li>
 			<li>SPSS, Statistica, GraphPad Prism </li>
  			<li>Reference Manager, EndNote, Zotero, Mendeley</li>
 			<li>ImageJ, Photoshop, Paint.net</li>
  			<li>Axiovision</li>
		</ul>
		<h2>Professional development</h2>
		<ul>
 			<li>Grant reviewer for Cancer charity, 2012    </li>
  			<li>Ad hoc reviewer for various international journals</li>
  			<li>Ad hoc grant reviewer National Medical Research Council from Singapore    </li>
  			<li>Leaderships skills, UEA, UK, 2011</li>
 			<li>Access 2003 Advanced course, KULeuven, Belgium, 2007 </li>
  			<li>Reference Manager course, KULeuven, Belgium, 2006</li>
 			<li>Biostatistics course, KULeuven, Belgium, 2005</li>
		</ul>
		<h2>Organizations</h2>
		<ul>
 		<li>British Society for Cell Biology (2012-present)</li>
 		<li>International Proteolysis Society (2007-2008)</li>
		</ul>
	</ul></div>
    
	<div class="TabbedPanelsContent">
    <ul>
  	  	<li> 2011 Company of Biologists summer studentship, UK</li>
  		<li> 2010 Big C summer studentship, UK</li>
	</ul></div>
    
    <div class="TabbedPanelsContent">
    <ul>
  		<li> Belgian nationality</li>
 		<li> owner of an European drivers license B</li>
  		<li> Language know-how: Dutch (native language), English (fluent), French (basic)</li>
  		<li> Personal license holder ‘Scientific Procedures on Living animals’, HOTC modules 1-3, Cambridge, 2009</li>
  		<li> Mobile: +44 (0)7942604702</li>
  		<li> e-mail: j.decock@uea.ac.uk</li>
  		<li> uk.linkedin.com/in/juliedecock</li>
	</ul></div>
    
    <div class="TabbedPanelsContent">
  	<ul>
  		<li> Thirkettle S, <strong>Decock J</strong>, Arnold H, Pennington CJ, Jaworski DM, Edwards DR. Matrix metalloproteinase-8 (collagenase-2) induces the expression of interleukins-6 and -8 in breast cancer cells. J Biol Chem. 2013 Apr 30. PubMed PMID: 23632023</li>
  		<li> Leivonen SK, Lazaridis K, Decock J, Chantry A, Edwards DR, Kähäri VM. TGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38α, and ERK1/2. PLoS One. 2013;8(2):e57474. doi: 10.1371/journal.pone.0057474. PubMed PMID: 23468994</li>
  		<li> Decock J, Thirkettle S, Wagstaff L, Edwards DR. Matrix metalloproteinases: protective roles in cancer. J Cell Mol Med. 2011, 15(6):1254-65. Review.</li>
 		 <li> Wagstaff L, Kelwick R, <strong>Decock J</strong>, Edwards DR. The roles of ADAMTS metalloproteinases in tumorigenesis and metastasis. Front Biosc 2011, 16:1861-72.</li>
  		<li> Van Belle V, <strong>Decock J</strong>, Hendrickx W, Brouckaert O, Pintens S, Moerman P, Wildiers H, Paridaens R, Christiaens MR, Van Huffel S, Neven P. Short term prognostic index for breast cancer: NPI or Lpi. Pathol Res Int 2010; 2011:918408.</li>
  		<li> Neven, P; Van Calster, B; Van den Bempt, I; Van Huffel, S; Van Belle, V; Hendrickx, W;       Decock, J; Wildiers, H; Paridaens, R; Amant, F; Leunen, K; Berteloot, P; Timmerman, D; Van Limbergen, E; Weltens, C; Van den Bogaert, W; Smeets, A; Vergote, I; Christiaens, MR; Drijkoningen, M. Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer. Breast Cancer Res Treat 2008, 110 (1):153-159.</li>
  		<li> <strong>Decock J</strong>., Obermajer N., Vozelj S., Hendrickx W., Paridaens R. and Kos J. Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer. Int J Biol Markers 2008; 23(3):161-168. </li>
 		 <li>Brouckaert, O; Pintens, S; Van Belle, V; Van Huffel, S; Camerlynck, E; Amant, F; Leunen, K; Smeets, A; Berteloot, P; Van Limbergen, E; Decock, J; Hendrickx, W; Weltens, C; Van den Bogaert, W; Vanden Bempt, I; Drijkoningen, M; Paridaens, R; Wildiers, H; Vergote, I; Christiaens, MR; Neven, P. Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors. Breast Cancer Res Treat 2009; 115 (2):349-358.</li>
  		<li> <strong>Decock J</strong>, Hendrickx W, Vanleeuw U, Van Belle V, Van Huffel S, Christiaens MR, Ye S, Paridaens R. Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis. BMC Cancer 2008, 8:77.</li>
  		<li> Van Calster, B; Bempt, IV; Drijkoningen, M; Pochet, N; Cheng, JQ; Van Huffel, S; Hendrickx, W; Decock, J; Huang, HJ; Leunen, K; Amant, F; Berteloot, P; Paridaens, R; Wildiers, H; Van Limbergen, E; Weltens, C; Timmerman, D; Van Gorp, T; Smeets, A; Van den Bogaert, W; Vergote, I; Christiaens, MR; Neven, P. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive. Breast Cancer Res Teat 2009, 113 (1):181-187.</li>
  		<li> Decock J., Paridaens R., Ye S. Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer. Clin Genet 2008;73(3):197-211.</li>
  		<li> <strong>Decock J</strong>, Long JR, Laxton RC, Shu XO, Hodgkinson C, Hendrickx W, Pearce EG, Gao YT, Pereira AC, Paridaens R, Zheng W, Ye S. Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis. Cancer Res 2007; 67(21):10214-21. </li>
  		<li> De Brakeleer S, Bogdani M, De Grève J, <strong>Decock J</strong>, Sermijn E, Bonduelle M, Goelen G, Teugels E. Loss of nuclear BRCA protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers. Mutat Res 2007; 619 (1-2):104-12. </li>
  		<li><strong>Decock J</strong>, Hendrickx W, Drijkoningen M, Wildiers H, Neven P, Smeets A, Paridaens R. Matrix metalloproteinase expression patterns in luminal A breast carcinomas. Disease Markers 2007; 23(3):189-96. 
   		 <strong>Decock J</strong>. How accurate is the antiprimer Quenching-based Real-Time PCR for detection of Her2/neu in clinical cancer samples? Clin Chem 2006; 52(7):1438-9 </li>
  		<li> <strong>Decock J</strong>, Paridaens R, Cufer T. Proteases and metastasis: clinical relevance nowadays? Curr Opin Oncol 2005; 17 (6): 545-50. </li>
  		<li><strong>Decock J</strong>, Hendrickx W, Wildiers H, Christiaens MR, Neven P, Drijkoningen M, Paridaens R. Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status, Her2/neu expression and other clinicopathological variables. Clin Exp Metastasis 2005; 22 (6): 495-02. </li>
	</ul></div>
    
    <div class="TabbedPanelsContent">
  	<ul>
  		<li> <strong>Decock J</strong>, Hendrickx W, Stefan C, Neven P., Wildiers H., Christiaens MR., Smeets A. and Paridaens R. (2007) Characterization of breast cancer subtypes by immunohistochemistry in a large retrospective study. Chapter XIV of New Research on Tumor Markers, (Sinise G.A., ed.), Nova Science Publishers, Inc. (Hauppauge, NY), ISBN 1-60021-423-1</li>
	</ul></div>
</div>
</div>

<script type="text/javascript">
var TabbedPanels1 = new Spry.Widget.TabbedPanels("TabbedPanels1");
</script>

</body>
</html>
